Electric fields join chemo in fight against tough pancreatic cancer

NCT ID NCT07319910

TEMPORARILY_NOT_AVAILABLE Disease control Sponsor: NovoCure GmbH Source: ClinicalTrials.gov ↗

Summary

This program provides access to an experimental wearable device for adults with advanced pancreatic cancer that cannot be surgically removed. The device, worn on the torso, uses gentle electric fields aimed at slowing cancer growth. It is used together with standard chemotherapy drugs (gemcitabine and nab-paclitaxel) as part of ongoing treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

Explore the condition pages connected to this study.